1. Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines. (4th March 2018) Authors: Raikar, Sunil S.; Fleischer, Lauren C.; Moot, Robert; Fedanov, Andrew; Paik, Na Yoon; Knight, Kristopher A.; Doering, Christopher B.; Spencer, H. Trent Journal: Oncoimmunology Issue: Volume 7:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model. (3rd August 2019) Authors: Zoine, Jaquelyn T.; Knight, Kristopher A.; Fleischer, Lauren C.; Sutton, Kathryn S.; Goldsmith, Kelly C.; Doering, Christopher B.; Spencer, H. Trent Journal: Oncoimmunology Issue: Volume 8:Number 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗